| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $588.0M | -60.9% |
| Cost of Revenue | $279.6M | -68.4% |
| Gross Profit | $308.4M | -50.2% |
| R&D Expense | $97.9M | -49.5% |
| SG&A Expense | $169.2M | -46.1% |
| Operating Income | -$27.1M | -135.1% |
| Interest Expense | $6.4M | -51.7% |
| Pre-tax Income | -$63.9M | -139.5% |
| Income Tax | -$43.8M | -257.3% |
| Net Income | -$86.5M | -164.3% |
| EPS (Basic) | -$0.77 | -174.8% |
| EPS (Diluted) | -$0.77 | -179.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $446.6M | +137.1% |
| Accounts Receivable | $119.1M | -63.6% |
| Current Assets | $679.6M | -10.7% |
| Total Assets | $1.50B | -38.0% |
| Current Liabilities | $230.3M | -57.9% |
| Long-term Debt | $26.4M | +0.0% |
| Total Liabilities | $487.2M | -52.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $115.6M | +253.2% |
| Capital Expenditures | $2.1M | -61.1% |
| Investing Cash Flow | $585.1M | +4906.1% |
| Financing Cash Flow | -$444.9M | -71.9% |
| Free Cash Flow | $113.5M | +240.6% |
| Stockholders' Equity |
| $1.02B |
| -27.7% |